Rare diseases
Investigational molecules
Locations
138 conditions with trials, the busiest first
373 trials across Europe, recruiting first
Study on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease
AustriaStudy on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion
GermanyStudy on Ranibizumab Injections and Laser Treatment for Macular Edema in Central Retinal Vein Occlusion Patients
AustriaStudy on the Safety and Use of AVT06 (Aflibercept) for Patients with Chorioretinal Vascular Diseases
LatviaLong-Term Study on Aflibercept for Retinopathy of Prematurity in Infants
BelgiumStudy on Long-term Safety and Effectiveness of Bimatoprost SR for Patients with Open-angle Glaucoma or Ocular Hypertension
FranceStudy of Darovasertib for Patients with Localized Uveal Melanoma
FranceStudy on the Safety and Effects of CPK850 Gene Therapy for Patients with Retinitis Pigmentosa Due to RLBP1 Gene Mutations
SwedenStudy on Methotrexate for Maintaining Remission in Patients with Giant Cell Arteritis After Initial Treatment with Tocilizumab and Glucocorticoids
GermanyStudy on the Effects of Oral N-Acetylcysteine for Patients with Retinitis Pigmentosa
AustriaStudy on the Effects of RO7200220 for Adults and Children with Uveitic Macular Edema
AustriaStudy on the Effects of Obexelimab for Patients with IgG4-Related Disease
FranceThe therapies tested most often in Eye disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
